Fund shareholders of Regeneron Pharmaceuticals, Inc.
ISIN US75886F1075 · United States · LEI 549300RCBFWIRX3HYQ56
- Fund shareholders
- 1,130
- Of which ETFs
- 315 815 other funds
- Value held
- 30.8B $ 4.1B SEK · 102.9M €
1,130 funds hold this company. This table lists the 1,113 that declare it in a regulatory filing. The other 17 publish their holdings in their own reports. They are not in the table.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 3,300,592 | 2.6B $ | 0.13 % | as of Mar 31, 2026 ↗ |
| Dodge & Cox Stock Fund Dodge & Cox Funds | 2,908,804 | 2.2B $ | 1.96 % | as of Mar 31, 2026 ↗ |
| VANGUARD 500 INDEX FUND VANGUARD INDEX FUNDS | 2,561,770 | 2B $ | 0.14 % | as of Mar 31, 2026 ↗ |
| Invesco QQQ Trust, Series 1 Invesco QQQ Trust, Series 1 | 2,188,791 | 1.7B $ | 0.45 % | as of Mar 31, 2026 ↗ |
| iShares Core S&P 500 ETF iShares Trust | 1,296,727 | 1B $ | 0.14 % | as of Mar 31, 2026 ↗ |
| Fidelity 500 Index Fund Fidelity Concord Street Trust | 1,282,577 | 1B $ | 0.13 % | as of Feb 28, 2026 ↗ |
| Putnam Large Cap Value Fund Putnam Large Cap Value Fund | 1,142,625 | 807.9M $ | 1.61 % | as of Apr 30, 2026 ↗ |
| VANGUARD VALUE INDEX FUND VANGUARD INDEX FUNDS | 960,922 | 742.4M $ | 0.33 % | as of Mar 31, 2026 ↗ |
| VANGUARD HEALTH CARE FUND VANGUARD SPECIALIZED FUNDS | 931,886 | 658.9M $ | 1.79 % | as of Apr 30, 2026 ↗ |
| VANGUARD WELLINGTON FUND VANGUARD WELLINGTON FUND | 803,715 | 628.2M $ | 0.52 % | as of Feb 28, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 758,232 | 585.8M $ | 7.21 % | as of Mar 31, 2026 ↗ |
| State Street(R) Health Care Select Sector SPDR(R) ETF SELECT SECTOR SPDR TRUST | 733,541 | 566.8M $ | 1.47 % | as of Mar 31, 2026 ↗ |
| JPMorgan Equity Premium Income ETF J.P. Morgan Exchange-Traded Fund Trust | 696,057 | 537.8M $ | 1.22 % | as of Mar 31, 2026 ↗ |
| College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund | 633,057 | 489.1M $ | 0.38 % | as of Mar 31, 2026 ↗ |
| Growth Fund of America Growth Fund of America | 602,903 | 471.3M $ | 0.14 % | as of Feb 28, 2026 ↗ |
| College Retirement Equities Fund - Growth Account College Retirement Equities Fund | 586,888 | 453.5M $ | 1.21 % | as of Mar 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 568,388 | 439.2M $ | 0.14 % | as of Mar 31, 2026 ↗ |
| Loomis Sayles Growth Fund LOOMIS SAYLES FUNDS II | 511,945 | 395.5M $ | 2.47 % | as of Mar 31, 2026 ↗ |
| New Perspective Fund New Perspective Fund | 467,600 | 361.3M $ | 0.24 % | as of Mar 31, 2026 ↗ |
| Invesco NASDAQ 100 ETF Invesco Exchange-Traded Fund Trust II | 392,907 | 307.1M $ | 0.43 % | as of Feb 28, 2026 ↗ |
| Fidelity Contrafund Fidelity Contrafund | 377,811 | 291.9M $ | 0.19 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 373,226 | 288.4M $ | 2.65 % | as of Mar 31, 2026 ↗ |
| JPMorgan U.S. Equity Fund JPMorgan Trust I | 336,504 | 260M $ | 0.82 % | as of Mar 31, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 312,898 | 244.6M $ | 1.21 % | as of Feb 28, 2026 ↗ |
| Pacer US Cash Cows 100 ETF Pacer Funds Trust | 299,615 | 211.8M $ | 1.17 % | as of Apr 30, 2026 ↗ |
| Dodge & Cox Global Stock Fund Dodge & Cox Funds | 281,552 | 217.5M $ | 1.81 % | as of Mar 31, 2026 ↗ |
| JPMorgan Nasdaq Equity Premium Income ETF J.P. Morgan Exchange-Traded Fund Trust | 265,326 | 205M $ | 0.60 % | as of Mar 31, 2026 ↗ |
| Strategic Advisers U.S. Total Stock Fund Fidelity Rutland Square Trust II | 235,050 | 183.7M $ | 0.20 % | as of Feb 28, 2026 ↗ |
| iShares Russell 1000 Value ETF iShares Trust | 233,138 | 180.1M $ | 0.26 % | as of Mar 31, 2026 ↗ |
| Invesco Comstock Fund AIM Sector Funds (Invesco Sector Funds) | 227,473 | 160.8M $ | 1.12 % | as of Apr 30, 2026 ↗ |
| Schwab S&P 500 Index Fund SCHWAB CAPITAL TRUST | 222,933 | 157.6M $ | 0.11 % | as of Apr 30, 2026 ↗ |
| Dodge & Cox Balanced Fund Dodge & Cox Funds | 221,300 | 171M $ | 1.17 % | as of Mar 31, 2026 ↗ |
| Invesco S&P 500 Equal Weight ETF Invesco Exchange-Traded Fund Trust | 217,857 | 154M $ | 0.18 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio S&P 500(R) ETF SPDR SERIES TRUST | 211,946 | 163.8M $ | 0.14 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price U.S. Large-Cap Core Fund, Inc. T. ROWE PRICE U.S. LARGE-CAP CORE FUND, INC. | 206,337 | 159.4M $ | 0.97 % | as of Mar 31, 2026 ↗ |
| Schwab U.S. Large-Cap Growth ETF SCHWAB STRATEGIC TRUST | 193,316 | 151.1M $ | 0.30 % | as of Feb 28, 2026 ↗ |
| Putnam Focused Large Cap Value ETF Putnam ETF Trust | 190,831 | 149.2M $ | 1.70 % | as of Feb 27, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 188,515 | 147.4M $ | 0.12 % | as of Feb 28, 2026 ↗ |
| Nuveen Core Equity Fund TIAA-CREF Funds | 180,300 | 127.5M $ | 1.80 % | as of Apr 30, 2026 ↗ |
| Ultra Fund American Century Mutual Funds, Inc. | 176,000 | 124.4M $ | 0.47 % | as of Apr 30, 2026 ↗ |
| iShares S&P 500 Value ETF iShares Trust | 173,929 | 134.4M $ | 0.29 % | as of Mar 31, 2026 ↗ |
| AP7 Aktiefond Sjunde AP-fonden | 167,417 | 1.2B SEK | 0.09 % | as of Mar 31, 2026 ↗ |
| Fidelity SAI U.S. Low Volatility Index Fund Fidelity Salem Street Trust | 160,947 | 113.8M $ | 0.55 % | as of Apr 30, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 149,305 | 116.7M $ | 0.12 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Global Stock Fund T. ROWE PRICE INTERNATIONAL FUNDS, INC. | 148,123 | 104.7M $ | 1.28 % | as of Apr 30, 2026 ↗ |
| WisdomTree U.S. Quality Dividend Growth Fund WisdomTree Trust | 146,941 | 113.5M $ | 0.74 % | as of Mar 31, 2026 ↗ |
| Invesco Diversified Dividend Fund AIM Equity Funds (Invesco Equity Funds) | 137,739 | 97.4M $ | 0.92 % | as of Apr 30, 2026 ↗ |
| First Trust Rising Dividend Achievers ETF First Trust Exchange-Traded Fund VI | 133,885 | 103.4M $ | 0.52 % | as of Mar 31, 2026 ↗ |
| Invesco Equity and Income Fund AIM Counselor Series Trust (Invesco Counselor Series Trust) | 131,065 | 102.4M $ | 0.78 % | as of Feb 28, 2026 ↗ |
| JPMorgan Hedged Equity Fund JPMorgan Trust I | 128,094 | 99M $ | 0.49 % | as of Mar 31, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 126,655 | 97.9M $ | 0.12 % | as of Mar 31, 2026 ↗ |
| VANGUARD LARGE-CAP INDEX FUND VANGUARD INDEX FUNDS | 121,963 | 94.2M $ | 0.15 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio S&P 500(R) Value ETF SPDR SERIES TRUST | 118,704 | 91.7M $ | 0.29 % | as of Mar 31, 2026 ↗ |
| JPMorgan Value Advantage Fund JPMorgan Trust I | 118,100 | 91.2M $ | 1.13 % | as of Mar 31, 2026 ↗ |
| THE U.S. LARGE CAP VALUE SERIES DFA INVESTMENT TRUST CO | 117,321 | 83M $ | 0.28 % | as of Apr 30, 2026 ↗ |
| College Retirement Equities Fund - Global Equities Account College Retirement Equities Fund | 115,166 | 89M $ | 0.27 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 109,400 | 84.5M $ | 1.14 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 108,834 | 85.1M $ | 0.10 % | as of Feb 28, 2026 ↗ |
| Schwab U.S. Large-Cap ETF SCHWAB STRATEGIC TRUST | 103,695 | 81.1M $ | 0.13 % | as of Feb 28, 2026 ↗ |
| Nuveen Large Cap Value Fund TIAA-CREF Funds | 101,771 | 72M $ | 1.12 % | as of Apr 30, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 101,316 | 79.2M $ | 1.48 % | as of Feb 28, 2026 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 101,249 | 78.2M $ | 3.45 % | as of Mar 31, 2026 ↗ |
| Capital Group Global Growth Equity ETF Capital Group Global Growth Equity ETF | 98,421 | 76.9M $ | 0.81 % | as of Feb 28, 2026 ↗ |
| Parnassus Value Equity Fund Parnassus Funds | 97,495 | 75.3M $ | 1.63 % | as of Mar 31, 2026 ↗ |
| JPMorgan Active Value ETF J.P. Morgan Exchange-Traded Fund Trust | 96,683 | 74.7M $ | 1.25 % | as of Mar 31, 2026 ↗ |
| AMCAP Fund AMCAP Fund | 95,795 | 74.9M $ | 0.08 % | as of Feb 28, 2026 ↗ |
| S&P 500 Index Master Portfolio Master Investment Portfolio | 92,076 | 71.1M $ | 0.14 % | as of Mar 31, 2026 ↗ |
| ProShares UltraPro QQQ ProShares Trust | 88,823 | 69.4M $ | 0.25 % | as of Feb 28, 2026 ↗ |
| JPMorgan Equity Premium Income Fund JPMorgan Trust IV | 88,638 | 68.5M $ | 1.25 % | as of Mar 31, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 87,659 | 68.5M $ | 1.05 % | as of Feb 27, 2026 ↗ |
| Loomis Sayles Growth Portfolio Brighthouse Funds Trust I | 86,481 | 66.8M $ | 2.45 % | as of Mar 31, 2026 ↗ |
| Fidelity SAI U.S. Value Index Fund Fidelity Salem Street Trust | 85,643 | 60.6M $ | 0.75 % | as of Apr 30, 2026 ↗ |
| Nuveen Equity Index Fund TIAA-CREF Funds | 85,231 | 60.3M $ | 0.10 % | as of Apr 30, 2026 ↗ |
| iShares Core S&P U.S. Value ETF iShares Trust | 84,901 | 65.6M $ | 0.27 % | as of Mar 31, 2026 ↗ |
| Nuveen Dividend Value Fund Nuveen Investment Funds, Inc. | 84,110 | 59.5M $ | 1.71 % | as of Apr 30, 2026 ↗ |
| Global Growth Fund AMERICAN FUNDS INSURANCE SERIES | 83,600 | 64.6M $ | 0.75 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 82,104 | 58.1M $ | 0.06 % | as of Apr 30, 2026 ↗ |
| Select Fund American Century Mutual Funds, Inc. | 82,100 | 58M $ | 0.91 % | as of Apr 30, 2026 ↗ |
| JPMorgan Large Cap Value Fund JPMorgan Trust II | 81,980 | 63.3M $ | 1.28 % | as of Mar 31, 2026 ↗ |
| Handelsbanken Hälsovård Tema Handelsbanken Fonder AB | 77,000 | 566.7M SEK | 2.55 % | as of Mar 31, 2026 ↗ |
| AQR Long-Short Equity Fund AQR Funds | 75,942 | 58.7M $ | 0.73 % | as of Mar 31, 2026 ↗ |
| iShares Russell 1000 ETF iShares Trust | 72,670 | 56.1M $ | 0.13 % | as of Mar 31, 2026 ↗ |
| Tax-Managed U.S. Large Cap Fund RUSSELL INVESTMENT CO | 71,613 | 50.6M $ | 0.43 % | as of Apr 30, 2026 ↗ |
| JNL/WMC Balanced Fund JNL Series Trust | 66,113 | 51.1M $ | 0.58 % | as of Mar 31, 2026 ↗ |
| JPMorgan U.S. Research Enhanced Equity Fund JPMorgan Trust I | 66,058 | 51M $ | 0.50 % | as of Mar 31, 2026 ↗ |
| Longleaf Partners Fund Longleaf Partners Funds Trust | 65,506 | 50.6M $ | 4.82 % | as of Mar 31, 2026 ↗ |
| Invesco Growth and Income Fund AIM Counselor Series Trust (Invesco Counselor Series Trust) | 65,207 | 51M $ | 1.16 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Equity Index 500 Fund T. ROWE PRICE INDEX TRUST, INC. | 62,941 | 48.6M $ | 0.14 % | as of Mar 31, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 61,019 | 43.1M $ | 4.16 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 60,842 | 47.6M $ | 0.21 % | as of Feb 28, 2026 ↗ |
| Large Cap Index Master Portfolio Master Investment Portfolio | 60,678 | 46.9M $ | 0.13 % | as of Mar 31, 2026 ↗ |
| Putnam VT Large Cap Value Fund Putnam Variable Trust | 60,256 | 46.6M $ | 1.87 % | as of Mar 31, 2026 ↗ |
| JPMorgan U.S. Value Fund JPMorgan Trust I | 59,958 | 46.3M $ | 0.73 % | as of Mar 31, 2026 ↗ |
| ClearBridge Select Fund Legg Mason Partners Investment Trust | 59,900 | 42.4M $ | 1.32 % | as of Apr 30, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 59,432 | 42M $ | 0.10 % | as of Apr 30, 2026 ↗ |
| VANGUARD RUSSELL 1000 VALUE INDEX FUND VANGUARD SCOTTSDALE FUNDS | 59,132 | 46.2M $ | 0.25 % | as of Feb 28, 2026 ↗ |
| VANGUARD MEGA CAP VALUE INDEX FUND VANGUARD WORLD FUND | 58,678 | 45.9M $ | 0.38 % | as of Feb 28, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 58,558 | 45.8M $ | 0.12 % | as of Feb 28, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 58,478 | 45.2M $ | 0.08 % | as of Mar 31, 2026 ↗ |
| PGIM Jennison Health Sciences Fund Prudential Sector Funds, Inc. | 57,331 | 44.8M $ | 3.07 % | as of Feb 27, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Direxion Daily Biotech Top 5 Bull 2X ETF Direxion Shares ETF Trust | 8.55 % | as of Apr 30, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 7.51 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 7.21 % | as of Mar 31, 2026 ↗ |
| Amplify Weight Loss Drug & Treatment ETF Amplify ETF Trust | 6.77 % | as of Mar 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 6.03 % | as of Feb 28, 2026 ↗ |
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 5.46 % | as of Mar 31, 2026 ↗ |
| Longleaf Partners Global Fund Longleaf Partners Funds Trust | 4.83 % | as of Mar 31, 2026 ↗ |
| Longleaf Partners Fund Longleaf Partners Funds Trust | 4.82 % | as of Mar 31, 2026 ↗ |
| Invesco Biotechnology & Genome ETF Invesco Exchange-Traded Fund Trust | 4.77 % | as of Apr 30, 2026 ↗ |
| LIVE OAK HEALTH SCIENCES FUND Oak Associates Funds | 4.66 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 1,017 | +69 | 40,397,822 | +6.2 % |
| 2026Q1 | 948 | +29 | 38,042,108 | +7.4 % |
| 2025Q4 | 919 | +31 | 35,427,572 | -7.9 % |
| 2025Q3 | 888 | -76 | 38,464,142 | -8.2 % |
| 2025Q2 | 964 | +29 | 41,897,672 | -1.9 % |
| 2025Q1 | 935 | -91 | 42,717,919 | -8.6 % |
| 2024Q4 | 1,026 | -2 | 46,741,888 | -1.0 % |
| 2024Q3 | 1,028 | +4 | 47,228,499 | +0.0 % |
| 2024Q2 | 1,024 | +25 | 47,204,916 | +4.4 % |
| 2024Q1 | 999 | +5 | 45,210,158 | -5.5 % |
| 2023Q4 | 994 | 47,828,710 |
Institutional managers
1,377 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 8,947,735 | 6.9B $ | as of Mar 31, 2026 |
| STATE STREET CORP | 4,664,478 | 3.6B $ | as of Mar 31, 2026 |
| Dodge & Cox | 4,458,238 | 3.4B $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 4,311,806 | 3.2B $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 2,722,071 | 2.1B $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,607,732 | 2B $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2,177,527 | 1.7M $ | as of Mar 31, 2026 |
| Nuveen, LLC | 2,065,064 | 1.6B $ | as of Mar 31, 2026 |
| LOOMIS SAYLES & CO L P | 1,912,310 | 1.5B $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 1,837,459 | 1.4B $ | as of Mar 31, 2026 |
| Invesco Ltd. | 1,724,478 | 1.3B $ | as of Mar 31, 2026 |
| FMR LLC | 1,518,192 | 1.2B $ | as of Mar 31, 2026 |
| Capital World Investors | 1,419,000 | 1.1B $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,319,329 | 1B $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,300,558 | 1B $ | as of Mar 31, 2026 |
| AQR CAPITAL MANAGEMENT LLC | 1,231,008 | 946M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 1,189,584 | 919.1M $ | as of Mar 31, 2026 |
| Amundi | 1,009,798 | 780.2M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 941,941 | 727.8M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 812,236 | 627.6M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 804,508 | 621.6M $ | as of Mar 31, 2026 |
| Bank of New York Mellon Corp | 765,411 | 591.4M $ | as of Mar 31, 2026 |
| Legal & General Group Plc | 732,054 | 565.6M $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 723,621 | 559.1M $ | as of Mar 31, 2026 |
| DEUTSCHE BANK AG\ | 625,388 | 483.2M $ | as of Mar 31, 2026 |
Declared shareholders of Regeneron Pharmaceuticals, Inc.
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Vanguard Capital Management | 7.37 % | 7,660,810 | as of Mar 31, 2026 · SCHEDULE 13G |
Funds holding the debt of Regeneron Pharmaceuticals, Inc.
130 funds declare 156 bond lines of this company. The table shows the 25 largest holdings. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
Cite this page
Titelia. "Fund shareholders of Regeneron Pharmaceuticals, Inc.". https://titelia.com/en/stocks/regeneron-pharmaceuticals-inc-US75886F1075